This map shows the geographic impact of A J Scheen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A J Scheen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A J Scheen more than expected).
This network shows the impact of papers produced by A J Scheen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A J Scheen. The network helps show where A J Scheen may publish in the future.
Co-authorship network of co-authors of A J Scheen
This figure shows the co-authorship network connecting the top 25 collaborators of A J Scheen.
A scholar is included among the top collaborators of A J Scheen based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with A J Scheen. A J Scheen is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Scheen, A J, et al.. (2014). [Chronic liver diseases and diabetes].. PubMed. 10(433). 1254, 1256–60.2 indexed citations
2.
Scheen, A J. (2014). [Diagnosis and assessment of hypoglycemia in patients with diabetes mellitus].. PubMed. 69(2). 110–5.2 indexed citations
Scheen, A J, et al.. (2009). Vildagliptin (Galvus) and fixed combination vildagliptine-metformin (Eucreas) in the treatment of type 2 diabetes. Open Repository and Bibliography (University of Liège).1 indexed citations
6.
Scheen, A J, Marc D. Binder, L. Hanssens, et al.. (2007). P353 - Anomalies de la tolérance au glucose chez les patients schizophrènes traités par antipsychotiques de seconde génération : étude comparative prospective de 3 mois. The World Journal of Biological Psychiatry.2 indexed citations
Eyck, D Van, Marc D. Binder, Martien Wampers, et al.. (2005). Oral glucose tolerance tests in schizophrenia for "dummies," making sense of potentially predictive prediabetic insulin and glucose curves. Schizophrenia Bulletin. 31(2). 572–572.2 indexed citations
Scheen, A J. (2003). [Medication of the month. Gliclazide modified release (Uni Diamicron)].. PubMed. 58(10). 641–5.3 indexed citations
11.
Magis, Delphine, et al.. (2002). [Smoking, insulin resistance and type 2 diabetes].. Open Repository and Bibliography (University of Liège). 57(9). 575–81.12 indexed citations
Scheen, A J. (1998). Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials.. PubMed. 24(4). 311–20.62 indexed citations
14.
Grimaldi, André, Nadia Tubiana‐Rufi, A. Heurtier, et al.. (1997). [Hypoglycemia in the diabetic patient. Recommendations of ALFEDIAM].. PubMed. 23(1). 100–8.2 indexed citations
Paolisso, Giuseppe, A J Scheen, F D'Onofrio, & P. J. Lef�bvre. (1990). Magnesium and glucose homeostasis. Diabetologia. 33(9). 511–514.222 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.